National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Sollid LM(2026) One mechanism, two diseases: Involvement of enzyme-substrate complexes in the pathogenesis of celiac disease and rheumatoid arthritis Proc Natl Acad Sci U S A, 123(37), e2600933123 DOI 10.1073/pnas.2600933123, PubMed 42696555
Olsbø S, Larsen MH, Hermansen Å, Bjørnland K(2026) Health literacy profiles in parents of children with congenital colorectal disorders: A cluster analysis J Pediatr Surg, 163439(in press) DOI 10.1016/j.jpedsurg.2026.163439, PubMed 42692193
Drivet E, Tsykunova G, Egner IM, Lund KP, Goll GL, Tran HTT, Holme PA, Tvedt THA, Ghanima W, Munthe LA, Kared H(2026) Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia Haematologica(in press) DOI 10.3324/haematol.2026.301032, PubMed 42687820